Literature DB >> 10783938

The expression of lymphocyte surface antigens in bronchial biopsies, bronchoalveolar lavage cells and blood cells in healthy smoking and never-smoking men, 60 years old.

A Ekberg-Jansson1, B Andersson, E Avrå, O Nilsson, C G Löfdahl.   

Abstract

In this study we investigated if smoking subjects with a normal or slightly decreased lung function differ in the lymphocyte pattern compared to never-smokers. In a group of 'healthy' smokers (n = 58) and never-smokers (n = 34) 60 years old, we investigated the lymphocyte pattern in both BAL (n = 30 and n = 18 respectively), bronchial epithelium and lamina propria (n = 14 and n = 10 respectively) and blood. We found that all subjects, despite smoking history, had a higher number of CD8+ cells per mm2 in the epithelium compared to the lamina propria in the bronchial biopsies. In smokers, these CD8+ cells were significantly negatively correlated to FEV1 (r = -0.56, P = 0.04). In smokers, the number of CD8+ lymphocytes was higher and the T cell activation markers (CD57+ and CD28+) were lower in BAL, than in never-smokers. This last finding was also seen in blood for CD3+ 57+. We conclude, that in 'healthy' smokers the lymphocyte patterns are different compared to never-smokers, to some extent in BAL. There is also a relation between lymphocytes in the bronchial mucosa and lung function. This has previously been shown in patients with chronic obstructive pulmonary disease (COPD) and chronic bronchitis but not in asymptomatic smokers.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10783938     DOI: 10.1053/rmed.1999.0735

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  8 in total

1.  alphaEbeta7 expression on CD8+ T-cells in COPD BAL fluid and on TGF-beta stimulated T-cells in vitro.

Authors:  Pernilla S Glader; Claes-Göran A Löfdahl; Karin A von Wachenfeldt
Journal:  Lung       Date:  2005 Mar-Apr       Impact factor: 2.584

2.  Maintained smoking cessation for 6 months equilibrates the percentage of sputum CD8+ lymphocyte cells with that of nonsmokers.

Authors:  Izolde Bouloukaki; Maria Tsoumakidou; Constantine I Vardavas; Ioanna Mitrouska; Eleni Koutala; Nikolaos M Siafakas; Sophia E Schiza; Nikos Tzanakis
Journal:  Mediators Inflamm       Date:  2010-02-23       Impact factor: 4.711

Review 3.  Is CD69 an effective brake to control inflammatory diseases?

Authors:  Roberto González-Amaro; José R Cortés; Francisco Sánchez-Madrid; Pilar Martín
Journal:  Trends Mol Med       Date:  2013-08-13       Impact factor: 11.951

4.  Immunomodulatory effects of two different physical therapy modalities in patients with chronic obstructive pulmonary disease.

Authors:  Sherin Hassan M Mehani
Journal:  J Phys Ther Sci       Date:  2017-09-15

Review 5.  The Influence of Innate Lymphoid Cells and Unconventional T Cells in Chronic Inflammatory Lung Disease.

Authors:  Jessica G Borger; Maverick Lau; Margaret L Hibbs
Journal:  Front Immunol       Date:  2019-07-11       Impact factor: 7.561

6.  Altered effector function of peripheral cytotoxic cells in COPD.

Authors:  Richard A Urbanowicz; Jonathan R Lamb; Ian Todd; Jonathan M Corne; Lucy C Fairclough
Journal:  Respir Res       Date:  2009-06-22

7.  Bronchoalveolar lavage results are independent of season, age, gender and collection site.

Authors:  Helga H Olsen; Johan Grunewald; Göran Tornling; C Magnus Sköld; Anders Eklund
Journal:  PLoS One       Date:  2012-08-31       Impact factor: 3.240

8.  Differential activation of killer cells in the circulation and the lung: a study of current smoking status and chronic obstructive pulmonary disease (COPD).

Authors:  Jia Wang; Richard A Urbanowicz; Patrick J Tighe; Ian Todd; Jonathan M Corne; Lucy C Fairclough
Journal:  PLoS One       Date:  2013-03-11       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.